What question did this study set out to answer?

The aim is to evaluate KAT8 as a biomarker for predicting outcomes in hepatitis B virus-related acute-on-chronic liver failure.

March 8, 20261 citations

KAT8: A Promising Biomarker for the Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

The aim is to evaluate KAT8 as a biomarker for predicting outcomes in hepatitis B virus-related acute-on-chronic liver failure.
Assessment of KAT8 levels in patients with HBV-ACLF
Statistical analysis to correlate KAT8 with patient prognosis
Finding a significant relationship between KAT8 levels and patient outcomes
Suggesting that higher KAT8 levels may indicate poorer prognosis in HBV-ACLF patients

KAT8 may serve as a valuable biomarker for the prognosis prediction of patients with HBV-ACLF.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper